Related references
Note: Only part of the references are listed.Association of Genetic Polymorphisms in STAT1 Gene with Increased Risk of Hepatocellular Carcinoma
Zhong-Zheng Zhu et al.
ONCOLOGY (2010)
Treatment of Advanced Hepatocellular Carcinoma: Intraarterial Infusion Chemotherapy Combined with Interferon
Hiroaki Nagano
ONCOLOGY (2010)
Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activation
Atsushi Hosui et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Genomic dissection of the cytokine-controlled STAT5 signaling network in liver
Atsushi Hosui et al.
PHYSIOLOGICAL GENOMICS (2008)
Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration
Yongzhi Cui et al.
HEPATOLOGY (2007)
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage
Claire Dunn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
L Udabage et al.
EXPERIMENTAL CELL RESEARCH (2005)
Disruption of hepatocellular tight junctions by vascular endothelial growth factor (VEGF):: a novel mechanism for tumor invasion
M Schmitt et al.
JOURNAL OF HEPATOLOGY (2004)
Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-γ stimuli
A Hosui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis
Z von Marschall et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: A prospective study
RTP Poon et al.
ANNALS OF SURGERY (2001)
Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids
BV Diaz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
